By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Pacira Pharmaceuticals, Inc. 

10450 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-625-2414 Fax: 858-678-3999


SEARCH JOBS


Industry
Pharmaceutical






Company News
Pacira Pharmaceuticals, Inc. (PCRX) Announces Timing For Second Quarter 2014 Financial Results Webcast And Conference Call 7/17/2014 12:01:14 PM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Publication Of Pooled Results From IMPROVE Studies Evaluating Health Economic Benefits Of EXPAREL® 6/26/2014 10:13:24 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces sNDA Submission For EXPAREL Nerve Block Indication 5/7/2014 8:44:43 AM
Pacira Pharmaceuticals, Inc. (PCRX) To Present At The Bank of America (BAC) Merrill Lynch 2014 Health Care Conference 5/6/2014 7:07:53 AM
Pacira Pharmaceuticals, Inc. (PCRX) Reports First Quarter EXPAREL Revenue Of $34.4 Million And First Quarter 2014 Results 5/1/2014 2:50:02 PM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Timing For First Quarter 2014 Financial Results Webcast And Conference Call 4/17/2014 6:52:48 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Grants Of Inducement Stock Options Under NASDAQ Listing Rule 5635(c)(4) 4/16/2014 9:31:19 AM
Pacira Pharmaceuticals, Inc. (PCRX) Announces Proposed Public Offering Of Common Stock 4/8/2014 9:37:00 AM
Pacira Pharmaceuticals, Inc. (PCRX) Release: Exparel Use In Femoral Nerve Block For Total Knee Arthroplasty Further Supported By Additional Data From Phase 3 Pivotal Study, SNDA Submission Planned For Second Quarter 2014 4/7/2014 9:35:27 AM
Pacira Pharmaceuticals, Inc. (PCRX) Release: Two New Studies Support Use Of EXPAREL For Postsurgical Pain Management Following Total Joint Replacement 3/14/2014 1:30:16 PM
12345678910...
//-->